Janux Therapeutics Statistics

Total Valuation

JANX has a market cap or net worth of $1.72 billion. The enterprise value is $715.45 million.

Market Cap	1.72B
Enterprise Value	715.45M

Important Dates

The next estimated earnings date is Tuesday, May 6, 2025, after market close.

Earnings Date	May 6, 2025
Ex-Dividend Date	n/a

Share Statistics

JANX has 59.11 million shares outstanding. The number of shares has increased by 22.12% in one year.

Current Share Class	59.11M
Shares Outstanding	59.11M
Shares Change (YoY)	+22.12%
Shares Change (QoQ)	+4.03%
Owned by Insiders (%)	6.85%
Owned by Institutions (%)	83.96%
Float	37.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	147.53
Forward PS	962.24
PB Ratio	1.68
P/TBV Ratio	1.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	67.57
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 59.21, with a Debt / Equity ratio of 0.02.

Current Ratio	59.21
Quick Ratio	59.03
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -10.09% and return on invested capital (ROIC) is -8.73%.

Return on Equity (ROE)	-10.09%
Return on Assets (ROA)	-8.57%
Return on Invested Capital (ROIC)	-8.73%
Return on Capital Employed (ROCE)	-9.47%
Revenue Per Employee	$130,716
Profits Per Employee	-$851,778
Employee Count	81
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -44.81% in the last 52 weeks. The beta is 3.26, so JANX's price volatility has been higher than the market average.

Beta (5Y)	3.26
52-Week Price Change	-44.81%
50-Day Moving Average	31.97
200-Day Moving Average	43.85
Relative Strength Index (RSI)	49.13
Average Volume (20 Days)	1,060,753

Short Selling Information

The latest short interest is 10.10 million, so 17.09% of the outstanding shares have been sold short.

Short Interest	10.10M
Short Previous Month	10.50M
Short % of Shares Out	17.09%
Short % of Float	27.08%
Short Ratio (days to cover)	11.98

Income Statement

In the last 12 months, JANX had revenue of $10.59 million and -$68.99 million in losses. Loss per share was -$1.28.

Revenue	10.59M
Gross Profit	-57.80M
Operating Income	-98.85M
Pretax Income	-44.05M
Net Income	-68.99M
EBITDA	-96.79M
EBIT	-98.85M
Loss Per Share	-$1.28

Full Income Statement

Balance Sheet

The company has $1.03 billion in cash and $23.03 million in debt, giving a net cash position of $1.00 billion or $16.96 per share.

Cash & Cash Equivalents	1.03B
Total Debt	23.03M
Net Cash	1.00B
Net Cash Per Share	$16.96
Equity (Book Value)	1.02B
Book Value Per Share	17.32
Working Capital	1.02B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$43.81 million and capital expenditures -$359,000, giving a free cash flow of -$44.17 million.

Operating Cash Flow	-43.81M
Capital Expenditures	-359,000
Free Cash Flow	-44.17M
FCF Per Share	-$0.75

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-933.58%
Pretax Margin	-651.62%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

JANX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.12%
Shareholder Yield	-22.12%
Earnings Yield	-4.02%
FCF Yield	-2.57%

Analyst Forecast

The average price target for JANX is $91.25, which is 214.01% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$91.25
Price Target Difference	214.01%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	105.85%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

JANX has an Altman Z-Score of 34.14 and a Piotroski F-Score of 3.

Altman Z-Score	34.14
Piotroski F-Score	3